News

A rare and fatal form of muscular dystrophy has long posed a devastating diagnosis for children, primarily affecting boys.
Drug developer PepGen said on Wednesday it will discontinue development of its experimental therapy for Duchenne muscular dystrophy (DMD) after it failed to boost production of a protein in a ...
Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...
A Co Down woman is encouraging people living with a muscle wasting or weakening condition, their families and carers to join ...
Satellos Bioscience Inc. ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today ...
DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos ...
The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.
Taevion Norris' senior year was suddenly interrupted in March due to heart failure, forcing him to spend the tail end of his final year of high school in the hospital.
It had all the makings of a typical graduation party. Blue and yellow streamers lined the room. Signs were posted on the walls that said “Congrats Grad 2025,” “You did it” and “Made the grade.” In the ...
Firefighters will be in Capitola Village this weekend accepting donations on behalf of the Muscular Dystrophy Association ...
DWP also said that existing claimants will only be affected by the change at their next review - after the November ...
Queensburgh Bowling Club recently bought stickers to support the Reach for a Dream Foundation's Slipper Day initiative.